These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 6957899)

  • 21. Platelet MAO concentration and molecular activity: II. Comparison of normal and schizophrenic populations.
    Rose RM; Castellani S; Boeringa JA; Malek-Ahmadi P; Lankford DA; Bessman JD; Fritz RR; Denney CB; Denney RM; Abell CW
    Psychiatry Res; 1986 Feb; 17(2):141-51. PubMed ID: 2870529
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lymphocyte monoamine oxidase activity and chronic schizophrenia.
    DeLisi LE; Neckers LM; Staub RA; Zalcman SJ; Wyatt RJ
    Psychiatry Res; 1980 May; 2(2):179-86. PubMed ID: 6932061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Platelet monoamine oxidase activity in schizophrenia. Relationship to disease, treatment, institutionalization and outcome.
    Mann J; Thomas KM
    Br J Psychiatry; 1979 Apr; 134():366-71. PubMed ID: 36192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelet monoamine oxidase and plasma amine oxidase in psychiatric patients.
    Meltzer HY; Arora RC; Jackman H; Pscheidt G; Smith MD
    Schizophr Bull; 1980; 6(2):213-9. PubMed ID: 7375852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Platelet monoamine oxidase activity and genetic vulnerability to schizophrenia.
    Baron M; Levitt M; Gruen R; Kane J; Asnis L
    Am J Psychiatry; 1984 Jul; 141(7):836-42. PubMed ID: 6731631
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet monoamine oxidase and clinical phenomenology of schizophrenia.
    Baron M; Gruen R; Levitt M; Kane J
    Psychiatry Res; 1984 Mar; 11(3):205-9. PubMed ID: 6587413
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low platelet MAO activity in chronic schizophrenics: a long-term effect of neuroleptic treatment?
    Del Vecchio M; Maj M; D'Ambrosio A; Kemali D
    Psychopharmacology (Berl); 1983; 79(2-3):177-9. PubMed ID: 6133302
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blood tryptophan metabolism in chronic schizophrenics.
    Freedman DX; Belendiuk K; Belendiuk GW; Crayton JW
    Arch Gen Psychiatry; 1981 Jun; 38(6):655-9. PubMed ID: 7247628
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dopamine-beta-hydroxylase, monoamine oxidase, and schizophrenia.
    DeLisi LE; Wise CD; Potkin SG; Zalcman S; Phelps BH; Lovenberg W; Wyatt RJ
    Biol Psychiatry; 1980 Dec; 15(6):895-907. PubMed ID: 7459411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of neuroleptics on platelet monoamine oxidase activity.
    Ho BT; Smith RC; Kralik P; Allen R; Schoolar J; Khan M; DeJohn C
    Biol Psychiatry; 1982 Aug; 17(8):885-95. PubMed ID: 6126230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet monoamine oxidase in a pedigree with schizophrenia: an interlaboratory project.
    Ask AL; Böök JA; Heyden T; Ross SB; Unge C; Wetterberg L; Eiduson S; Kobayashi K
    Clin Genet; 1979 Apr; 15(4):289-99. PubMed ID: 436326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parents of high risk subjects defined by levels of monoamine oxidase activity.
    Puchall LB; Coursey RD; Buchsbaum MS; Murphy DL
    Schizophr Bull; 1980; 6(2):338-46. PubMed ID: 7375867
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic analysis of platelet monoamine oxidase activity in families of schizophrenic patients.
    Baron M; Risch N; Levitt M; Gruen R
    J Psychiatr Res; 1985; 19(1):9-21. PubMed ID: 3989738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monoamine oxidase in schizophrenia: an overview.
    Wyatt RJ; Potkin SG; Bridge TP; Phelps BH; Wise CD
    Schizophr Bull; 1980; 6(2):199-207. PubMed ID: 7375851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Platelet monamine oxidase in schizophrenia. An investigation in drug-free chronic hospitalized patients.
    Owen F; Bourne R; Crow TJ; Johnstone EC; Bailey AR; Hershon HI
    Arch Gen Psychiatry; 1976 Nov; 33(11):1370-3. PubMed ID: 791182
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Schizophrenia and platelet monoamine oxidase: research strategies.
    Buchsbaum MS; Coursey RD; Murphy DL
    Schizophr Bull; 1980; 6(2):375-84. PubMed ID: 6103578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet monoamine oxidase activity in acute schizophrenia: relationship to symptomatology and neuroleptic medication.
    Owen F; Bourne RC; Crow TJ; Fadhli AA; Johnstone EC
    Br J Psychiatry; 1981 Jul; 139():16-22. PubMed ID: 7296184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship of auditory hallucinations and paranoia to platelet MAO activity in schizophrenics: sex and race interactions.
    Meltzer HY; Zureick JL
    Psychiatry Res; 1987 Oct; 22(2):99-109. PubMed ID: 3685225
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors affecting determination of platelet monoamine oxidase activity.
    Jackman HL; Meltzer HY
    Schizophr Bull; 1980; 6(2):259-66. PubMed ID: 6103575
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Measurement of platelet monoamine oxidase using three different substrates in patients with alcoholism and schizophrenia.
    Tsuji M
    Folia Psychiatr Neurol Jpn; 1985; 39(4):521-30. PubMed ID: 3833630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.